{"id":58008,"date":"2026-02-26T16:00:23","date_gmt":"2026-02-26T08:00:23","guid":{"rendered":"https:\/\/flcube.com\/?p=58008"},"modified":"2026-02-26T16:00:24","modified_gmt":"2026-02-26T08:00:24","slug":"danaher-to-acquire-masimo-for-9-9b-expands-diagnostics-platform-with-pulse-oximetry-leader","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=58008","title":{"rendered":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader"},"content":{"rendered":"\n<p><strong>Danaher Corporation<\/strong> announced a definitive agreement to acquire <strong>Masimo Corporation (<a href=\"https:\/\/www.google.com\/finance\/quote\/MASI:NASDAQ\">NASDAQ:\u202fMASI<\/a>)<\/strong>, a <strong>leading professional diagnostics company<\/strong> specializing in <strong>pulse oximetry and patient monitoring solutions<\/strong>, for <strong>$180 per share in cash<\/strong>. The transaction values Masimo at approximately <strong>USD\u202f9.9\u202fbillion<\/strong> (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Danaher Corporation<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Masimo Corporation (NASDAQ:\u202fMASI)<\/td><\/tr><tr><td><strong>Transaction Value<\/strong><\/td><td><strong>~\u202fUSD\u202f9.9\u202fbillion<\/strong> (enterprise value)<\/td><\/tr><tr><td><strong>Per Share Price<\/strong><\/td><td><strong>$180<\/strong> (cash)<\/td><\/tr><tr><td><strong>Target Specialization<\/strong><\/td><td>Pulse oximetry, patient monitoring, acute care diagnostics<\/td><\/tr><tr><td><strong>Post\u2011Closing Structure<\/strong><\/td><td>Standalone company within Danaher&#8217;s Diagnostics platform<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-danaher-diagnostics-portfolio\">Danaher Diagnostics Portfolio<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Existing Brands<\/th><th>New Addition<\/th><\/tr><\/thead><tbody><tr><td>Radiometer<\/td><td><strong>Masimo<\/strong> (pulse oximetry, patient monitoring)<\/td><\/tr><tr><td>Leica Biosystems<\/td><td><\/td><\/tr><tr><td>Cepheid<\/td><td><\/td><\/tr><tr><td>Beckman Coulter Diagnostics<\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Diagnostics Platform Expansion:<\/strong> Masimo&#8217;s <strong>pulse oximetry leadership<\/strong> and <strong>acute care monitoring solutions<\/strong> complement Danaher&#8217;s existing diagnostics capabilities, creating a comprehensive <strong>patient monitoring to laboratory diagnostics<\/strong> continuum.<\/li>\n\n\n\n<li><strong>Acute Care Focus:<\/strong> Masimo&#8217;s <strong>hospital\u2011centric solutions<\/strong> (operating rooms, ICUs, emergency departments) align with Danaher&#8217;s strategy to capture high\u2011acuity, high\u2011value care settings.<\/li>\n\n\n\n<li><strong>Technology Synergies:<\/strong> Integration of Masimo&#8217;s <strong>non\u2011invasive monitoring innovations<\/strong> with Danaher&#8217;s diagnostic platforms could yield next\u2011generation <strong>connected care solutions<\/strong> and data analytics offerings.<\/li>\n\n\n\n<li><strong>Standalone Autonomy:<\/strong> Operating as a <strong>standalone entity<\/strong> preserves Masimo&#8217;s brand equity, customer relationships, and innovation culture while leveraging Danaher&#8217;s operational excellence and global scale.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>Pulse Oximetry Market<\/strong><\/td><td>Masimo holds dominant market share; acquisition consolidates Danaher&#8217;s position in critical care monitoring<\/td><\/tr><tr><td><strong>Patient Monitoring Trends<\/strong><\/td><td>Growing demand for continuous, non\u2011invasive monitoring in acute and ambulatory settings<\/td><\/tr><tr><td><strong>Diagnostics M&amp;A Momentum<\/strong><\/td><td>$9.9B deal signals continued consolidation in medtech; Danaher reinforces commitment to healthcare diagnostics<\/td><\/tr><tr><td><strong>Competitive Dynamics<\/strong><\/td><td>Combined entity challenges Abbott, Medtronic, and Philips in integrated monitoring and diagnostics<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding transaction closing, integration execution, and synergies realization. Actual results may differ due to risks including regulatory approvals, antitrust scrutiny, and post\u2011merger integration challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics&#8230;<\/p>\n","protected":false},"author":1,"featured_media":58010,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[535,4624,4625],"class_list":["post-58008","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-danaher","tag-masimo","tag-nasdaq-masi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=58008\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader\" \/>\n<meta property=\"og:description\" content=\"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=58008\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-26T08:00:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T08:00:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader\",\"datePublished\":\"2026-02-26T08:00:23+00:00\",\"dateModified\":\"2026-02-26T08:00:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008\"},\"wordCount\":342,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2604.webp\",\"keywords\":[\"Danaher\",\"Masimo\",\"NASDAQ:\u202fMASI\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58008#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=58008\",\"name\":\"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2604.webp\",\"datePublished\":\"2026-02-26T08:00:23+00:00\",\"dateModified\":\"2026-02-26T08:00:24+00:00\",\"description\":\"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58008\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2604.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2604.webp\",\"width\":1080,\"height\":608,\"caption\":\"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58008#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader - Insight, China&#039;s Pharmaceutical Industry","description":"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=58008","og_locale":"en_US","og_type":"article","og_title":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader","og_description":"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.","og_url":"https:\/\/flcube.com\/?p=58008","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-26T08:00:23+00:00","article_modified_time":"2026-02-26T08:00:24+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=58008#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=58008"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader","datePublished":"2026-02-26T08:00:23+00:00","dateModified":"2026-02-26T08:00:24+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=58008"},"wordCount":342,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=58008#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","keywords":["Danaher","Masimo","NASDAQ:\u202fMASI"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=58008#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=58008","url":"https:\/\/flcube.com\/?p=58008","name":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=58008#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=58008#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","datePublished":"2026-02-26T08:00:23+00:00","dateModified":"2026-02-26T08:00:24+00:00","description":"Danaher Corporation announced a definitive agreement to acquire Masimo Corporation (NASDAQ:\u202fMASI), a leading professional diagnostics company specializing in pulse oximetry and patient monitoring solutions, for $180 per share in cash. The transaction values Masimo at approximately USD\u202f9.9\u202fbillion (including debt assumption, net of cash), representing a major consolidation in the medical diagnostics and monitoring sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=58008#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=58008"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=58008#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","width":1080,"height":608,"caption":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=58008#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Danaher to Acquire Masimo for $9.9B \u2013 Expands Diagnostics Platform with Pulse Oximetry Leader"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2604.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58008"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58008\/revisions"}],"predecessor-version":[{"id":58011,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58008\/revisions\/58011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/58010"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}